Table 3. Laboratory blood analysis, mean ± SE.
CHF NYHA II out patients n = 15 | CHF NYHA IV hospitalized n = 20 | |
NT pro BNP (ng/L) | 1959 ± 569 | 16859 ± 1966* |
Hemoglobin (g/L) | 143 ± 3.7 | 116.5 ± 4.8* |
Sodium (mmol/L) | 141 ± 0.9 | 141 ± 1.1 |
Potassium (mmol/L) | 4.2 ± 0.1 | 3.9 ± 0.1 |
Creatinine (µmol/L) | 96.8 ± 5.4 | 152.7 ± 16.0* |
Uric acid (µmol/L) | 450 ± 21 | 559 ± 36* |
LDL (mmol/L) | 3.1 ± 0.2 | 2.1 ± 0.2 |
HDL (mmol/L) | 1.8 ± 0.2 | 1.1 ± 0.1* |
CRP (mg/L) | 4.7 ± 0.7 | 13.3 ± 4.6* |
HbA1c (%) | 4.8 ± 0.1 | 7.0 ± 0.3* |
IL-6 (ng/L) | 5.8 ± 2.1 | 7.0 ± 0.3* |
IL-2r (kU/L) | 666 ± 88 | 1127 ± 123* |
CHF: Congestive heart failure; NYHA: New York Heart Association classification; NT pro BNP: Nerve terminal-pro-brain natriuretic peptide; LDL: Low density lipoprotein; HDL: High density lipoprotein; CRP: Sensitive C Reactive Protein; IL: Interleukin; IL-2r: Soluble IL 2 receptor. *P < 0.05 compared between the two groups.